GRI Bio Capital Expenditures (CapEx) Growth & History (GRI)
GRI Bio's capital expenditures (capex) was $3,000 for fiscal 2025.
View full GRI Bio company overviewGRI Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3,000 | $3,000 | — |
| 2024 | 2024-12-31 | $0 | −$8,000 | — |
| 2023 | 2023-12-31 | $8,000 | $5,000 | +166.67% |
| 2022 | 2022-12-31 | $3,000 | $3,000 | — |
| 2021 | 2021-12-31 | $0 | −$2,000 | — |
| 2020 | 2020-12-31 | $2,000 | — | — |
GRI Bio quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q4 2020 | 2020-12-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $2,000 | — | — |
GRI Bio capital expenditures (capex) trends
Over the last five fiscal years, GRI Bio's capital expenditures (capex) increased from $2,000 to $3,000, a change of $1,000. The latest reported quarter, Q3 2024, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GRI Bio source filings ↗